Will Medicare Price Negotiations Really Cut Rheum Drug Costs?
— Initial analysis suggests Inflation Reduction Act provision will pay off
By John Gever for MedPage Today on March 20, 2025
Negotiations to set prices Medicare will pay for the original branded version of etanercept, Enbrel, should bring the government some genuine savings, and may indirectly make it more affordable for everyone, a new analysis indicated. Read here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.